Literature DB >> 19527543

Historical development of health technology assessment in Thailand.

Yot Teerawattananon1, Sripen Tantivess, Jomkwan Yothasamut, Pritaporn Kingkaew, Kakanang Chaisiri.   

Abstract

OBJECTIVES: This study aims to review the development of health technology assessment (HTA), including the socioeconomic context, outputs, and policy utilization in the Thai setting.
METHODS: This study was conducted through extensive document reviews including these published in both domestic and international literature.
RESULTS: Evidence suggests that contextual elements of the health system, especially the country's economic status and health financing reforms, as well as their effects on government budgeting for medical and public health services, played an important role in the increasing needs and demands for HTA information among policy makers. In the midst of substantial economic growth during the years 1982 to 1996, several studies reported the rapid diffusion and poor distribution of health technologies, and inequitable access to high-cost technology in public and private hospitals. At the same time, economic analysis and its underpinning concept of efficiency were suggested by groups of scholars and health officials to guide national policy on the investment in health technology equipment. Related research and training programs were subsequently launched. However, none of these HTA units could be institutionalized into national bodies. From 1997 to 2005, an economic recession, followed by the introduction of a universal health coverage plan, triggered the demands for effective measures for cost containment and prioritization of health interventions. This made policy makers and researchers at the Ministry of Public Health (MOPH) pay increasing attention to economic appraisals, and several HTA programs were established in the Ministry. Despite the rising number of Thai health economic publications, a major problem at that period involved the poor quality of studies. Since 2006, economic recovery and demands from different interests to include expensive technologies in the public health benefit package have been crucial factors promoting the role of HTA in national policy decisions. Meanwhile, HTA capacity has been strengthened through the establishment of many health economic and HTA initiatives. An illustration of the work and contributions of the Health Intervention and Technology Assessment Program (HITAP) is provided. In this phase, HTA policy integration has been enhanced through different mechanisms and organizations.
CONCLUSION: Over the past two decades a notable progression has been made in relation to the capacity building of HTA research and its policy utility in Thailand. Such development has been shaped by multiple factors. It is anticipated that experience gained among academics, health officials, and civil society organizations will be helpful not only in sustaining the momentum but also in improving formal HTA systems in the future.

Mesh:

Year:  2009        PMID: 19527543     DOI: 10.1017/S0266462309090709

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  24 in total

Review 1.  How contexts and issues influence the use of policy-relevant research syntheses: a critical interpretive synthesis.

Authors:  Kaelan A Moat; John N Lavis; Julia Abelson
Journal:  Milbank Q       Date:  2013-09       Impact factor: 4.911

Review 2.  Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Authors:  Sripen Tantivess; Yot Teerawattananon; Anne Mills
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Health related quality of life among patients with tuberculosis and HIV in Thailand.

Authors:  Wanitchaya Kittikraisak; Pritaporn Kingkaew; Yot Teerawattananon; Jomkwan Yothasamut; Supalert Natesuwan; Weerawat Manosuthi; Virasakdi Chongsuvivatwong; Sara J Whitehead
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

4.  Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand.

Authors:  Christine Y Lu; Isabel Cristina M Emmerick; Peter Stephens; Dennis Ross-Degnan; Anita K Wagner
Journal:  J Pharm Policy Pract       Date:  2015-02-16

5.  Policies and programs to facilitate access to targeted cancer therapies in Thailand.

Authors:  Rosarin Sruamsiri; Dennis Ross-Degnan; Christine Y Lu; Nathorn Chaiyakunapruk; Anita K Wagner
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

6.  Patient access schemes in Asia-pacific markets: current experience and future potential.

Authors:  Christine Y Lu; Caitlin Lupton; Shana Rakowsky; Zaheer-Ud-Din Babar; Dennis Ross-Degnan; Anita K Wagner
Journal:  J Pharm Policy Pract       Date:  2015-02-16

Review 7.  Institutionalising health technology assessment: establishing the Medical Technology Assessment Board in India.

Authors:  Laura E Downey; Abha Mehndiratta; Ashoo Grover; Vijay Gauba; Kabir Sheikh; Shankar Prinja; Ravinder Singh; Francoise A Cluzeau; Saudamini Dabak; Yot Teerawattananon; Sanjiv Kumar; Soumya Swaminathan
Journal:  BMJ Glob Health       Date:  2017-06-26

8.  Strengthening expertise for health technology assessment and priority-setting in Africa.

Authors:  Jane E Doherty; Thomas Wilkinson; Ijeoma Edoka; Karen Hofman
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

9.  Healthcare Databases in Thailand and Japan: Potential Sources for Health Technology Assessment Research.

Authors:  Surasak Saokaew; Takashi Sugimoto; Isao Kamae; Chayanin Pratoomsoot; Nathorn Chaiyakunapruk
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

10.  Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE.

Authors:  Sripen Tantivess; Kalipso Chalkidou; Nattha Tritasavit; Yot Teerawattananon
Journal:  F1000Res       Date:  2017-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.